Levi Gc
Impact in
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Emergency Medicine top 10%
- HIV-related health complications and treatments
Papers in
-
- Parasites and Host Interactions 4
- Parasitic Infections and Diagnostics 2
- Toxoplasma gondii Research Studies 1
-
- Parasitic Diseases Research and Treatment 2
- Antifungal resistance and susceptibility 1
- HIV/AIDS Research and Interventions 1
- Journals
- The Lancet (1 paper)PubMed (7 papers)
- Partner nations
- BrazilThailandNetherlands
In The Last Decade
Levi Gc
9 papers receiving 547 citations
Levi Gc's Hit Papers
Peers
Comparison fields: 5 of 35
- Infectious Diseases 466
- Emergency Medicine 48
- Pharmacology 48
- Virology 17
- Parasitology 24
Countries citing papers authored by Levi Gc
This map shows the geographic impact of Levi Gc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levi Gc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levi Gc more than expected).
Fields of papers citing papers by Levi Gc
This network shows the impact of papers produced by Levi Gc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levi Gc. The network helps show where Levi Gc may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study Hit paper breakdown → | 2004 | 573 |
| 2 | Efficacy of various drugs in treatment of giardiasis: comparative study. | 1978 | 8 |
| 3 | [Presence of Toxoplasma gondii in saliva of patients with toxoplasmosis. Eventual importance of such verification concerning the transmission of the disease (preliminary report)]. | 1968 | 6 |
| 4 | Disseminated Strongyloides stercoralis Infection in an AIDS Patient: The Role of Suppressive Therapy. | 1997 | 6 |
| 5 | [Our 1st observations on the therapeutic action of mebendazole, new anthelmintic drug, with a broad spectrum of action]. | 1973 | 4 |
| 6 | Management of Opportunistic Infections in HIV(+) Patients: Contrasts Between Europe and South America. | 1998 | 4 |
| 7 | [Treatment of ascaridiasis in a rural area: comparative study between the action of single doses of piperazine hexa-hydrate, tetramisole and pyrantel pamoate]. | 1973 | 2 |
| 8 | Tratamento das parasitoses intestinais. | 1982 | 1 |
| 9 | [Meningitis caused by Candida]. | 1986 | 1 |
About Levi Gc
Levi Gc is a scholar working on Parasitology, Infectious Diseases, Small Animals, Epidemiology and Public Health, Environmental and Occupational Health, having authored 9 papers that have together received 605 indexed citations. Recurring topics across this work include Parasites and Host Interactions (4 papers), Parasitic Diseases Research and Treatment (2 papers), Parasitic Infections and Diagnostics (2 papers), Antifungal resistance and susceptibility (1 paper), HIV/AIDS Research and Interventions (1 paper), Fungal Infections and Studies (1 paper), Helminth infection and control (1 paper) and Toxoplasma gondii Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (466 citations), Emergency Medicine (48 citations), Pharmacology (48 citations), Virology (17 citations) and Parasitology (24 citations). Levi Gc has collaborated with scholars based in Brazil, Thailand and Netherlands. Their work appears in journals such as The Lancet and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.